Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Resistance to polymyxins in Gram-negative organisms.

Jeannot K, Bolard A, Plésiat P.

Int J Antimicrob Agents. 2017 Feb 3. pii: S0924-8579(17)30032-8. doi: 10.1016/j.ijantimicag.2016.11.029. [Epub ahead of print]

PMID:
28163137
2.

Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.

Chalhoub H, Pletzer D, Weingart H, Braun Y, Tunney MM, Elborn JS, Rodriguez-Villalobos H, Plésiat P, Kahl BC, Denis O, Winterhalter M, Tulkens PM, Van Bambeke F.

Sci Rep. 2017 Jan 16;7:40208. doi: 10.1038/srep40208.

3.

A case of multiple contamination with methylase ArmA-producing pathogens.

Janvier F, Otto MP, Jové T, Mille A, Contargyris C, Meaudre E, Brisou P, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2017 Feb;72(2):618-620. doi: 10.1093/jac/dkw418. No abstract available.

PMID:
28073962
4.

First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.

Al-Agamy MH, Jeannot K, El-Mahdy TS, Shibl AM, Kattan W, Plésiat P, Courvalin P.

Microb Drug Resist. 2016 Nov 17. [Epub ahead of print]

PMID:
27854148
5.

Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

Cabot G, López-Causapé C, Ocampo-Sosa AA, Sommer LM, Domínguez MÁ, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Plesiat P, Oliver A.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7415-7423.

PMID:
27736752
6.

Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia.

Al-Agamy MH, Jeannot K, El-Mahdy TS, Samaha HA, Shibl AM, Plésiat P, Courvalin P.

Can J Infect Dis Med Microbiol. 2016;2016:4379686. doi: 10.1155/2016/4379686.

7.

Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.

Hocquet D, Petitjean M, Rohmer L, Valot B, Kulasekara HD, Bedel E, Bertrand X, Plésiat P, Köhler T, Pantel A, Jacobs MA, Hoffman LR, Miller SI.

Environ Microbiol. 2016 Oct;18(10):3482-3493. doi: 10.1111/1462-2920.13336.

PMID:
27119970
8.

Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10. doi: 10.1128/AAC.02622-15.

9.

Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia.

Riou M, Avrain L, Carbonnelle S, El Garch F, Pirnay JP, De Vos D, Plésiat P, Tulkens PM, Van Bambeke F.

Int J Antimicrob Agents. 2016 Jan;47(1):77-83. doi: 10.1016/j.ijantimicag.2015.11.004.

PMID:
26691019
10.

Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae.

Dortet L, Cuzon G, Plésiat P, Naas T.

J Antimicrob Chemother. 2016 Jan;71(1):135-40. doi: 10.1093/jac/dkv308.

PMID:
26462984
11.

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.

Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P.

Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55. doi: 10.1128/AAC.00825-15.

12.

The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Li XZ, Plésiat P, Nikaido H.

Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14. Review.

13.

Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.

Richardot C, Plésiat P, Fournier D, Monlezun L, Broutin I, Llanes C.

Int J Antimicrob Agents. 2015 May;45(5):529-32. doi: 10.1016/j.ijantimicag.2014.12.029.

PMID:
25735764
14.

Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.

Mazurier S, Merieau A, Bergeau D, Decoin V, Sperandio D, Crépin A, Barbey C, Jeannot K, Vicré-Gibouin M, Plésiat P, Lemanceau P, Latour X.

Appl Environ Microbiol. 2015 Apr;81(7):2579-90. doi: 10.1128/AEM.04160-14.

15.

Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients.

Chalhoub H, Tunney M, Elborn JS, Vergison A, Denis O, Plésiat P, Kahl BC, Van Bambeke F, Tulkens PM.

J Antimicrob Chemother. 2015 May;70(5):1596-8. doi: 10.1093/jac/dku551. No abstract available.

PMID:
25587996
16.

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Lucchetti-Miganeh C, Redelberger D, Chambonnier G, Rechenmann F, Elsen S, Bordi C, Jeannot K, Attrée I, Plésiat P, de Bentzmann S.

Pathogens. 2014 Apr 10;3(2):309-40. doi: 10.3390/pathogens3020309.

17.

Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Segonds C, Thouverez M, Barthe A, Bossuet-Greif N, Tisseyre L, Plésiat P, Vergnaud G, Chabanon G, Pourcel C.

J Clin Microbiol. 2015 Feb;53(2):398-409. doi: 10.1128/JCM.02473-14.

18.

Drug susceptibility testing by dilution methods.

Jeannot K, Plésiat P.

Methods Mol Biol. 2014;1149:49-58. doi: 10.1007/978-1-4939-0473-0_6.

PMID:
24818896
19.

Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital.

Molina L, Udaondo Z, Duque E, Fernández M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P, Jeannot K, Ramos JL.

PLoS One. 2014 Jan 17;9(1):e81604. doi: 10.1371/journal.pone.0081604.

20.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.

Items per page

Supplemental Content

Loading ...
Support Center